Ensign Peak Advisors, Inc Regeneron Pharmaceuticals, Inc. Transaction History
Ensign Peak Advisors, Inc
- $51.2 Billion
- Q1 2025
A detailed history of Ensign Peak Advisors, Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 43,676 shares of REGN stock, worth $21.1 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
43,676
Previous 41,649
4.87%
Holding current value
$21.1 Million
Previous $29.7 Million
6.63%
% of portfolio
0.05%
Previous 0.05%
Shares
22 transactions
Others Institutions Holding REGN
# of Institutions
1,470Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.54 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.08 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.73 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.31 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$1.93 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $51.8B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...